Resistant Starch for Blood Sugar

Resistant starch is the part of the starch in food that is not broken down in the small intestine. It reaches the large bowel intact, and the bacteria living there ferment it. It occurs in whole foods such as legumes, whole grains, green bananas and potatoes or rice that have been cooked and then cooled. It is also made as an isolated starch powder, and many of the trials below tested the powder, not the food.

State of the evidence: in randomized trials, resistant starch most consistently lowered the rise in blood sugar after the meal that contained it. For insulin sensitivity, fasting glucose and hemoglobin A1C (HbA1c) the results are split. Some trials and pooled analyses found an improvement, others found none, and one meta-analysis of 22 randomized controlled trials concluded that short-term supplementation with type 2 resistant starch is “of limited cardiometabolic benefit”.


Table of Contents

  1. What Resistant Starch Is
  2. How It Affects Blood Sugar
  3. What the Trials Found on Blood Sugar After Meals
  4. What the Trials Found on Insulin Sensitivity
  5. What the Trials Found on Fasting Glucose and Hemoglobin A1C
  6. Safety Findings
  7. Limits of the Evidence
  8. Key Research Papers
  9. Connections
  10. Featured Videos

What Resistant Starch Is

Starch is the main carbohydrate in grains, potatoes and legumes. It is built from long chains of glucose. Enzymes in the small intestine cut most of it into single glucose units, which pass into the blood.

A 2001 review defines resistant starch as “starch and products of its small intestinal digestion that enter the large bowel”. It lists several reasons a starch escapes digestion: its chemical structure, the cooking of the food, chemical modification, and how thoroughly the food is chewed (PMID 11427691).

A 2023 systematic review and meta-analysis sorts resistant starch into types by the reason it escapes the digestive enzymes (PMID 37051127):

The review also names a type 5, which its summary does not define, and states that types 3, 4 and 5 require further research.

As general food-science background, not a trial finding: amylose is the straight-chain form of starch, which packs tightly and digests slowly. Retrogradation is what happens when a cooked starchy food cools and part of the softened starch sets back into a firm structure. Type 1 is the starch inside whole or coarsely milled grains, seeds and legumes. Type 2 is found in raw potato, green (unripe) bananas and high-amylose maize. Type 3 forms when potatoes, rice and other starchy foods are cooked and then cooled.

The trials match that background. One describes cooked, then chilled potatoes as “a source of” resistant starch (PMID 33119948), and another describes native banana starch as high in it (PMID 34836304).

Back to Table of Contents

How It Affects Blood Sugar

Two separate things happen, in two different parts of the gut.

Where starch goes after a meal Where starch goes after a meal 1. Small intestine Enzymes cut ordinary starch into glucose. The glucose enters the blood: blood sugar rises. Resistant starch is not cut here. It passes through without becoming glucose. resistant starch moves on, undigested 2. Colon (large bowel) Gut bacteria ferment the resistant starch. They make short-chain fatty acids, mainly: acetate propionate butyrate Sources: PMID 11427691 and PMID 37051127 (reviews)

In the small intestine: less glucose from the meal

Starch that is not digested in the small intestine does not enter the blood there as glucose. The 2023 systematic review states the other side of this: rapidly digestible starch raises blood sugar after a meal (PMID 37051127).

A 2023 narrative review of 31 randomized trials adds a caution. The fall in blood sugar after a meal was more pronounced when the test meal and the comparison meal were not matched for available (digestible) carbohydrate (PMID 37149926). In those trials, part of the effect is that the meal delivered less digestible starch.

In the colon: fermentation to short-chain fatty acids

Bacteria in the human colon ferment resistant starch to short-chain fatty acids, mainly acetate, propionate and butyrate. Butyrate is a preferred fuel for the cells lining the colon, and some types of resistant starch favor butyrate production (review, PMID 11427691).

Fermentation differs from one starch to another and from one person to another. In an intervention study, 174 healthy young adults took resistant starch from potatoes, resistant starch from maize, inulin from chicory root, or a digestible corn starch for 2 weeks. The potato starch gave the greatest rise in total short-chain fatty acids, including butyrate. The maize starch and the inulin did not significantly raise fecal butyrate. The response depended on which bacterial species lived in each person's gut (PMID 30696735).

What remains unexplained

How fermentation in the colon would change the body's response to insulin is not established. In a 12-week randomized trial in which insulin sensitivity improved, body weight, fat stored in muscle, liver and abdomen, vascular function and markers of inflammation did not change, and the authors wrote that the mechanism remains unclear (PMID 20536509).

Back to Table of Contents

What the Trials Found on Blood Sugar After Meals

This is the outcome with the most agreement. Throughout this page, amounts are what the researchers gave to trial participants, not amounts for a reader.

Pooled analysis and review

A 2023 systematic review and meta-analysis found 36 randomized controlled trials (982 participants) in people with type 2 diabetes or prediabetes; 31 could be pooled. It reports standardized mean differences (SMD), a way of combining trials that measured the same thing on different scales. An SMD is not a blood-sugar reading; a negative value means lower with resistant starch (PMID 37051127).

The 2023 narrative review reports that most 1-day trials in healthy adults showed improved blood sugar after the meal, whatever the type or amount of resistant starch (PMID 37149926).

Rice bred to be high in resistant starch

Randomized, open, crossover trial, 17 patients with type 2 diabetes. Each patient ate a test meal of a newly developed high-resistant-starch rice and a test meal of white rice. The total area under the plasma glucose curve was lower with the new rice: difference −8223 mg·min/dL (95% confidence interval −10100 to −6346, p < 0.001). The area under the insulin curve was also lower (p = 0.004) (PMID 36997485).

Randomized, double-blinded, controlled trial in patients with type 2 diabetes. With a naturally cultured high-resistant-starch rice, the rise in blood glucose was 2.80 ± 1.38 mmol/L against 3.04 ± 1.50 mmol/L with ordinary rice at 30 minutes (P = 0.043), and 3.94 ± 2.25 against 4.25 ± 2.29 mmol/L at 60 minutes (P = 0.036). The summary does not give the number of patients (PMID 36643977).

Isolated starches in type 2 diabetes

Randomized crossover trial, 17 people with well-controlled type 2 diabetes. After 12 weeks of 40 g a day of a high-amylose maize starch (type 2), blood glucose after a test meal was significantly lower than after 12 weeks of placebo (P = 0.045) (PMID 24671124).

Randomized crossover trial, 17 people with type 2 diabetes. Participants took native banana starch, high-amylose maize starch or digestible maize starch for 4 days each, matched for digestible starch content, then had a 6-hour meal test on day 5. Native banana starch reduced fasting blood glucose, the peak in blood glucose and the insulin response. The authors reported that it did more for glucose metabolism than the high-amylose maize starch (PMID 37083722).

A trial that found no improvement

Randomized crossover trial with continuous glucose monitoring, 17 people with type 2 diabetes. The same research group gave the same three starches for 4 days each. Both resistant starches induced an increase in 24-hour mean blood glucose during days 2 to 4 (p < 0.05). On day 4 only, three calculated indices of glucose swings and glucose exposure were higher with the high-amylose maize starch than with the digestible starch. Native banana starch did reduce the change in fasting blood glucose from baseline (p = 0.0074). The authors concluded that resistant starch from the two sources did not improve glycemic control or glycemic variability (PMID 34836304).

Back to Table of Contents

What the Trials Found on Insulin Sensitivity

Insulin sensitivity is how strongly the body responds to its own insulin; low insulin sensitivity is called insulin resistance. Most trials below measured it with laboratory tests in which glucose and insulin are given into a vein.

Randomized trials that measured insulin sensitivity. Results differ by sex, by starting insulin sensitivity and by whether diabetes was present.
Who was tested What they took Result for insulin sensitivity Source
20 insulin-resistant adults (single-blind, parallel groups) 40 g a day of resistant starch or placebo, 12 weeks Improved compared with placebo (P = 0.023) PMID 20536509
11 men and 22 women with a large waist (double-blind crossover) 0, 15 or 30 g a day of a high-amylose maize starch, 4 weeks each Men: higher after 15 g and after 30 g than after the control starch (P < 0.05), with no difference between the two amounts. Women: no difference among the treatments PMID 22357745
40 healthy women without diabetes, aged 22–67 (double-blind crossover) 15 and 30 g a day of a high-amylose maize starch given as cookies, or placebo, 4 weeks each Insulin-resistant women: about 16% higher after the 30 g arm than after the control arm (P < 0.05). Insulin-sensitive women: no effect PMID 26766961
37 adults with overweight or obesity (placebo-controlled crossover) Resistant starch as a dietary supplement, 8 weeks Insulin resistance improved; mean weight loss 2.8 kg PMID 38409604
17 adults with well-controlled type 2 diabetes (crossover) 40 g a day of a high-amylose maize starch or placebo, 12 weeks No effect on insulin sensitivity of the liver or of the rest of the body PMID 24671124
19 adults with a body mass index of 27.0–39.9 (pilot crossover) 300 g of cooked, then chilled potatoes (approximately two potatoes, about 18 g of resistant starch) over one 24-hour period, or control foods Not significantly different. This was the trial's primary endpoint PMID 33119948

In the trial in women, the 16% figure comes from an analysis of all 40 participants. Among the 23 women who completed every arm, insulin sensitivity “tended to be” 23% higher, which did not reach statistical significance (P = 0.06).

What the reviews found on insulin measures

Back to Table of Contents

What the Trials Found on Fasting Glucose and Hemoglobin A1C

Fasting glucose is blood sugar measured after a night without food. HbA1c reflects average blood sugar over roughly the previous two to three months, so a trial lasting a day or a few weeks cannot show a change in it. Four pooled analyses reached different answers.

Four pooled analyses of resistant starch trials. Negative values mean lower with resistant starch.
Analysis What was pooled Fasting glucose HbA1c
Meta-analysis, 2019 (PMID 31168050) 13 studies, 428 subjects with a body mass index of 25 or more Reduced: SMD −0.26 (95% confidence interval −0.5 to −0.02); in trials in people with diabetes, SMD −0.28 (−0.54 to −0.01) Reduced: SMD −0.43 (−0.74 to −0.13)
Meta-analysis of type 2 resistant starch, 2019 (PMID 31398841) 22 randomized controlled trials, 670 participants, at least 8 g a day No effect No effect
Meta-analysis, 2020 (PMID 31661295) 19 trials in metabolic syndrome and related disorders Reduced: weighted mean difference −4.28 (−7.01 to −1.55), 14 studies Reduced: weighted mean difference −0.60 (−0.95 to −0.24), 8 studies
Systematic review and meta-analysis, 2023 (PMID 37051127) 31 randomized controlled trials in type 2 diabetes or prediabetes Type 2 resistant starch, longer studies: SMD −0.39 (−0.66 to −0.13) Not reported in the summary

The 2020 summary gives its weighted mean differences without units. The 2019 meta-analysis that found reductions describes its 13 studies as case-control studies, and its authors wrote that the result “should be carefully taken into account” because of individual differences and the composition of the gut bacteria.

The 2019 meta-analysis of type 2 resistant starch set out to measure body weight, fullness ratings, fasting plasma glucose, HbA1c, insulin resistance and blood fats. It found lower triglycerides in healthy individuals and lower body weight in people with type 2 diabetes, and states that type 2 resistant starch “had no effects on any other metabolic outcomes”. It adds that those two positive results were heavily influenced by a small number of studies that contradicted the conclusions of the majority of trials.

Individual trials

Back to Table of Contents

Safety Findings

Triglycerides and body weight rose in some trials

Triglycerides are the main fat carried in the blood. Two trials found them higher with resistant starch.

Other records point the other way. One meta-analysis found triglycerides lower in healthy individuals (mean difference −0.10 mmol/L) and body weight lower in people with type 2 diabetes (mean difference −1.29 kg) (PMID 31398841); another found no effect on triglycerides (PMID 31661295). The effect on blood fats and weight is not settled.

Average blood sugar rose in one short trial

In the 4-day continuous glucose monitoring trial in 17 people with type 2 diabetes, both native banana starch and high-amylose maize starch induced an increase in 24-hour mean blood glucose during days 2 to 4 (PMID 34836304).

Gas from fermentation

Fermentation in the colon produces gas, including hydrogen, some of which leaves the body in the breath. In the chilled-potato trial, breath hydrogen after the next morning's breakfast was higher than after the control foods (P = 0.037) (PMID 33119948). None of the trial summaries behind this page reports how often participants had bloating, wind or loose stools, so this page gives no figure for them.

Resistant starch alongside diabetes medication

No record behind this page tested resistant starch in place of diabetes medication. The trials compared it with a placebo, a digestible starch or an ordinary staple food. None of the trial summaries reports low blood sugar (hypoglycemia) as a side effect.

Insulin and sulfonylurea drugs cause low blood sugar when the dose is larger than a meal requires, and a meal that delivers less glucose than the dose was set for is one such situation. The signs of low blood sugar are shakiness, sweating, a fast heartbeat and confusion, and at lower levels seizure or loss of consciousness.

Type 1 diabetes

Type 1 diabetes is a state of absolute insulin deficiency. No food, starch or diet replaces insulin; without insulin, diabetic ketoacidosis develops, and it is fatal if untreated. The individual trials described on this page enrolled people with type 2 diabetes, people at risk for it, or adults without diabetes.

One starch is not another

Resistant starch products differ in source and type, so a trial result for one does not transfer to another. Potato starch raised butyrate where maize starch did not, and banana starch outperformed maize starch on blood sugar measures in the same patients. None of the trial summaries reports data from pregnancy or from children.

Back to Table of Contents

Limits of the Evidence

Back to Table of Contents

Key Research Papers

  1. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81(3):1031-64. PubMed PMID: 11427691
  2. Pugh JE, Cai M, Altieri N, Frost G. A comparison of the effects of resistant starch types on glycemic response in individuals with type 2 diabetes or prediabetes: A systematic review and meta-analysis. Front Nutr. 2023;10:1118229. PubMed PMID: 37051127
  3. Maiya M, Adorno A, Toulabi SB, Tucker WJ, Patterson MA. Resistant starch improves cardiometabolic disease outcomes: A narrative review of randomized trials. Nutr Res. 2023;114:20-40. PubMed PMID: 37149926
  4. Wang Y, Chen J, Song YH, Zhao R, Xia L, Chen Y, et al. Effects of the resistant starch on glucose, insulin, insulin resistance, and lipid parameters in overweight or obese adults: a systematic review and meta-analysis. Nutr Diabetes. 2019;9(1):19. PubMed PMID: 31168050
  5. Snelson M, Jong J, Manolas D, Kok S, Louise A, Stern R, et al. Metabolic Effects of Resistant Starch Type 2: A Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2019;11(8):1833. PubMed PMID: 31398841
  6. Halajzadeh J, Milajerdi A, Reiner Ž, Amirani E, Kolahdooz F, Barekat M, et al. Effects of resistant starch on glycemic control, serum lipoproteins and systemic inflammation in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled clinical trials. Crit Rev Food Sci Nutr. 2020;60(18):3172-3184. PubMed PMID: 31661295
  7. Johnston KL, Thomas EL, Bell JD, Frost GS, Robertson MD. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med. 2010;27(4):391-7. PubMed PMID: 20536509
  8. Maki KC, Pelkman CL, Finocchiaro ET, Kelley KM, Lawless AL, Schild AL, et al. Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men. J Nutr. 2012;142(4):717-23. PubMed PMID: 22357745
  9. Gower BA, Bergman R, Stefanovski D, Darnell B, Ovalle F, Fisher G, et al. Baseline insulin sensitivity affects response to high-amylose maize resistant starch in women: a randomized, controlled trial. Nutr Metab (Lond). 2016;13:2. PubMed PMID: 26766961
  10. Li H, Zhang L, Li J, Wu Q, Qian L, He J, et al. Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota. Nat Metab. 2024;6(3):578-597. PubMed PMID: 38409604
  11. Bodinham CL, Smith L, Thomas EL, Bell JD, Swann JR, Costabile A, et al. Efficacy of increased resistant starch consumption in human type 2 diabetes. Endocr Connect. 2014;3(2):75-84. PubMed PMID: 24671124
  12. Sanders LM, Dicklin MR, Palacios OM, Maki CE, Wilcox ML, Maki KC. Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross-over randomised controlled trial. J Hum Nutr Diet. 2021;34(1):94-105. PubMed PMID: 33119948
  13. Nakamura Y, Takemoto A, Oyanagi T, Tsunemi S, Kubo Y, Nakagawa T, et al. Effects of cooked rice containing high resistant starch on postprandial plasma glucose, insulin, and incretin in patients with type 2 diabetes. Asia Pac J Clin Nutr. 2023;32(1):48-56. PubMed PMID: 36997485
  14. Tan LL, Duan WQ, Chen MX, Mei Y, Qi XY, Zhang Y. Naturally cultured high resistant starch rice improved postprandial glucose levels in patients with type 2 diabetes: A randomized, double-blinded, controlled trial. Front Nutr. 2022;9:1019868. PubMed PMID: 36643977
  15. García-Vázquez C, Ble-Castillo JL, Arias-Córdova Y, Ramos-García M, Olvera-Hernández V, Guzmán-Priego CG, et al. Effects of resistant starch on glycemic response, postprandial lipemia and appetite in subjects with type 2 diabetes. Eur J Nutr. 2023;62(5):2269-2278. PubMed PMID: 37083722
  16. Arias-Córdova Y, Ble-Castillo JL, García-Vázquez C, Olvera-Hernández V, Ramos-García M, Navarrete-Cortes A, et al. Resistant Starch Consumption Effects on Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes: A Randomized Crossover Study. Nutrients. 2021;13(11):4052. PubMed PMID: 34836304
  17. Meng Y, Bai H, Yu Q, Yan J, Zhao L, Wang S, et al. High-Resistant Starch, Low-Protein Flour Intervention on Patients With Early Type 2 Diabetic Nephropathy: A Randomized Trial. J Ren Nutr. 2019;29(5):386-393. PubMed PMID: 30982743
  18. Kim KN, Kang MS, Joo NS, Lee HR, Jung S, Ju S, et al. Effects of Resistant Starch on Metabolic Markers and Gut Microbiota in Women with Metabolic Syndrome Risk Factors: A Randomized, Double-Blind, Pilot Study. Nutrients. 2025;17(23):3652. PubMed PMID: 41373942
  19. Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM. Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. mBio. 2019;10(1):e02566-18. PubMed PMID: 30696735

PubMed Topic Searches

  1. PubMed: resistant starch and blood glucose after meals
  2. PubMed: resistant starch and insulin sensitivity
  3. PubMed: resistant starch in type 2 diabetes
  4. PubMed: resistant starch and short-chain fatty acids

Back to Table of Contents

Connections